These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 11011276

  • 1. [Infraclinical breast lesions: apropos of a retrospective study of 261 cases].
    Miras T, Seffert P, Mehdi A.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):469-77. PubMed ID: 11011276
    [Abstract] [Full Text] [Related]

  • 2. Role of US-guided fine-needle aspiration with on-site cytopathologic evaluation in management of nonpalpable breast lesions.
    Buchbinder SS, Gurell DS, Tarlow MM, Salvatore M, Suhrland MJ, Kader K.
    Acad Radiol; 2001 Apr; 8(4):322-7. PubMed ID: 11293780
    [Abstract] [Full Text] [Related]

  • 3. Quality of diagnosis and surgical management of breast lesions in a community hospital: room for improvement?
    Hanley C, Kessaram R.
    Can J Surg; 2006 Jun; 49(3):185-92. PubMed ID: 16749979
    [Abstract] [Full Text] [Related]

  • 4. Three-dimensional targeting: a new three-dimensional ultrasound technique to evaluate needle position during breast biopsy.
    Weismann CF, Forstner R, Prokop E, Rettenbacher T.
    Ultrasound Obstet Gynecol; 2000 Sep; 16(4):359-64. PubMed ID: 11169313
    [Abstract] [Full Text] [Related]

  • 5. [Retrospective evaluation of surgically treated cases of non-palpable breast tumor].
    Dubecz S, Petri K, Szabó E, Riedl E, Péley G, Rahóty P, Bak M, Köves I.
    Magy Seb; 2001 Aug; 54(4):203-7. PubMed ID: 11550484
    [Abstract] [Full Text] [Related]

  • 6. Stereotactic core needle biopsy of nonpalpable breast lesions using a conventional mammography unit with an add-on device.
    Kirshenbaum KJ, Voruganti T, Overbeeke C, Kirshenbaum MD, Patel P, Kaplan G, Maker V, August C, Cavallino RP.
    AJR Am J Roentgenol; 2003 Aug; 181(2):527-31. PubMed ID: 12876040
    [Abstract] [Full Text] [Related]

  • 7. Stereotaxic needle-core biopsy and fine-needle aspiration biopsy in the diagnosis of nonpalpable breast lesions: controversies and future prospects.
    Lifrange E, Kridelka F, Colin C.
    Eur J Radiol; 1997 Jan; 24(1):39-47. PubMed ID: 9056148
    [Abstract] [Full Text] [Related]

  • 8. Ultrasound guided fine needle aspiration cytology versus core biopsy in the preoperative assessment of non-palpable breast lesions.
    Ahmed ME, Ahmad I, Akhtar S.
    J Ayub Med Coll Abbottabad; 2010 Jan; 22(2):138-42. PubMed ID: 21702288
    [Abstract] [Full Text] [Related]

  • 9. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
    Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ.
    Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
    [Abstract] [Full Text] [Related]

  • 10. Nonpalpable breast cancer: needle-localized biopsy for diagnosis and considerations for treatment.
    Marrujo G, Jolly PC, Hall MH.
    Am J Surg; 1986 May; 151(5):599-602. PubMed ID: 3010754
    [Abstract] [Full Text] [Related]

  • 11. Nonpalpable breast lesions: findings of stereotaxic needle-core biopsy and fine-needle aspiration cytology.
    Dowlatshahi K, Yaremko ML, Kluskens LF, Jokich PM.
    Radiology; 1991 Dec; 181(3):745-50. PubMed ID: 1947091
    [Abstract] [Full Text] [Related]

  • 12. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ, Tadros T, Hilton G, Birdsong G.
    Acta Cytol; 1993 Dec; 37(4):461-71. PubMed ID: 8328240
    [Abstract] [Full Text] [Related]

  • 13. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography.
    Vural G, Atasever T, Ozdemir A, Oznur I, Karabacak NI, Gökçora N, Işik S, Unlü M.
    Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879
    [Abstract] [Full Text] [Related]

  • 14. [Radioguided excision of non-palpable breast lesions with simultaneous sentinel lymph node biopsy].
    Rényi-Vámos F, Péley G, Bidlek M, Sinkovics I, Szabó E, Keresztes S, Farkas E, Orosz Z, Köves I.
    Magy Seb; 2003 Feb; 56(1):9-15. PubMed ID: 12764987
    [Abstract] [Full Text] [Related]

  • 15. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA.
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation.
    Verkooijen HM, Core Biopsy After Radiological Localisation (COBRA) Study Group.
    Int J Cancer; 2002 Jun 20; 99(6):853-9. PubMed ID: 12115488
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D.
    Ann Intern Med; 2003 Aug 19; 139(4):274-84. PubMed ID: 12965983
    [Abstract] [Full Text] [Related]

  • 18. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
    Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, Fernandez-Rodriguez J, Rotmensz N, Latronico A, Berrettini A, Mauri M, Machado L, Luini A, Paganelli G.
    Ann Surg Oncol; 2007 Oct 19; 14(10):2928-31. PubMed ID: 17674108
    [Abstract] [Full Text] [Related]

  • 19. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M, Scheiber M, Cajulis R, Keebler CM, Wied GL, Dowlatshahi K.
    Acta Cytol; 1988 Oct 19; 32(2):193-201. PubMed ID: 2831687
    [Abstract] [Full Text] [Related]

  • 20. [The surgical treatment of nonpalpable breast lesions].
    Rosato L, Paino O, Ginardi A.
    Minerva Chir; 1997 Oct 19; 52(10):1199-202. PubMed ID: 9471572
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.